Serum levels of soluble CD200 proteins have the potential to become a diagnostic tool for breast cancer, and the level of CD200R may offer some idea of the stages of the disease, but these studies still require additional confirmation and validation [5,38,39]. Here, CD200 is linked to breast carcinoma.